Deepening Knowledge
Building on scientific evidence

Science · Innovation · People
A continuous journey. A brighter tomorrow.
From organ-specific cells to iPSCs: an overview of different cell technologies and their research context.
FOUR MILESTONES. A STRONGER TOMORROW.
Cell therapy has evolved significantly over the past decades, from organ-specific cells to induced pluripotent stem cells (iPSCs). Each milestone has expanded our understanding of biology and opened new possibilities for research and clinical application.
Swiss Stem Cell company evolution milestones, not dates of scientific discovery. iPSC and iPSC 3.0 refer to the same technology context on this website.
Cells from specific organs or tissues, studied in relation to tissue-specific functions.
A heterogeneous group of cells studied for differentiation and signalling properties.
Pluripotent cells derived from early embryos, with the capacity to form many specialised cell types.
Adult cells reprogrammed to a pluripotent state, opening possibilities for disease modelling and research.
MORE KNOWLEDGE. MORE POSSIBILITIES.
CONTINUING THE PURSUIT OF BETTER HEALTH.
As science advances, we remain committed to evidence-based research and responsible development in the field of regenerative medicine.
Building on scientific evidence
Advancing research and innovation
Through science, for future generations
Discreet. Personalised. Exceptional.
A healthier tomorrow
begins with a conversation.